User profiles for M. Mason

Michael Mason

- Verified email at umche.maine.edu - Cited by 8376

Malia F. Mason

- Verified email at columbia.edu - Cited by 7733

EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent

…, TB Lam, M Lardas, M Liew, MD Mason… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer

…, M Bolla, S Joniau, T van der Kwast, M Mason… - European urology, 2014 - Elsevier
… Patients received CBS 25 mg/m 2 and prednisone 5 mg twice daily at 21-d intervals for 10
cycles or mitoxantrone 12 mg/m 2 and prednisone 5 mg twice daily at 21-d intervals for 10 …

EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer

…, TB Lam, M Lardas, M Liew, MD Mason… - European urology, 2021 - Elsevier
… All trials compared between ADT alone as the standard of care and ADT combined with
immediate docetaxel (75 mg/m 2 every 3 wk; within 3 mo of ADT initiation). The primary objective …

[HTML][HTML] 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer

…, JL Donovan, JA Lane, M Mason… - … England Journal of …, 2016 - Mass Medical Soc
Background The comparative effectiveness of treatments for prostate cancer that is detected
by prostate-specific antigen (PSA) testing remains uncertain. Methods We compared active …

EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent

…, T Gross, AM Henry, S Joniau, TB Lam, MD Mason… - European urology, 2017 - Elsevier
Mason is a company consultant for Bristol-Myers Squibb, Janssen, Bayer, Sanofi, and
Dendreon, and he receives company speaker honoraria from Takeda and Bayer. Seva Matveev …

Wandering minds: the default network and stimulus-independent thought

MF Mason, MI Norton, JD Van Horn, DM Wegner… - science, 2007 - science.org
Despite evidence pointing to a ubiquitous tendency of human minds to wander, little is known
about the neural operations that support this core component of human cognition. Using …

Sample size and saturation in PhD studies using qualitative interviews

M Mason - Forum qualitative Sozialforschung/Forum …, 2010 - qualitative-research.net
… Mark MASON has spent more than fifteen years in public sector environments carrying
out, commissioning, managing and disseminating research. He began his career working in …

EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013

…, M Bolla, S Joniau, T van der Kwast, M Mason… - European urology, 2014 - Elsevier
… Skeletal metastasis (M staging) is best assessed by bone scan. This procedure may not be
indicated in asymptomatic patients if the serum PSA level is <20 ng/ml in the presence of well-…

[HTML][HTML] Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive …

ND James, MR Sydes, NW Clarke, MD Mason… - The Lancet, 2016 - thelancet.com
Background Long-term hormone therapy has been the standard of care for advanced prostate
cancer since the 1940s. STAMPEDE is a randomised controlled trial using a multiarm, …

[HTML][HTML] Ultra-high resolution imaging by fluorescence photoactivation localization microscopy

ST Hess, TPK Girirajan, MD Mason - Biophysical journal, 2006 - cell.com
Biological structures span many orders of magnitude in size, but far-field visible light
microscopy suffers from limited resolution. A new method for fluorescence imaging has been …